
|Articles|October 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Antimicrobial Use
- Volume 4
- Issue 11 Suppl
Optimizing Antimicrobial Therapy and Emerging Pathogens
Author(s)David P. Nicolau, PharmD
Advertisement
Articles in this issue
about 27 years ago
Participating Facultyabout 27 years ago
Introductionabout 27 years ago
Mechanisms and Current Rates of Resistanceabout 27 years ago
Influence of Antibiotics on the Normal Floraabout 27 years ago
Therapeutic Pathways for Antimicrobial Use: General Overviewabout 27 years ago
Therapeutic Pathways for Antimicrobial Use: Pediatric Issuesabout 27 years ago
Pharmacoeconomic Impact of Appropriate Clinical Pathwaysabout 27 years ago
CME QuizNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
2
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
3
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
4
Making the Genetic Models Match the Ancestry of Patient Populations
5














































